TG Therapeutics, Inc. (NASDAQ:TGTX) Q3 2025 Earnings Call Transcript November 3, 2025
TG Therapeutics, Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $0.24.
Operator: Greetings, and welcome to the TG Therapeutics’ Third Quarter Earnings Call and Webcast. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to your host, Jenna Bosco, Chief Communications Officer. Please go ahead.
Jenna Bosco: Thank you....
